Take a look at this post at 33 Charts.
What an honor. I am working on bringing Brian Vartabedian to Kidney Week 2014 to speak about social median in medicine. Looks like I picked the right guy.

musings of a salt whisperer
Take a look at this post at 33 Charts.
What an honor. I am working on bringing Brian Vartabedian to Kidney Week 2014 to speak about social median in medicine. Looks like I picked the right guy.
This summer, through luck and/or moxie I was able to land a plum position on the KDIGO team charged with building the mobile app. The team partnered with the crazy effective nerds at Visible Health to push out our initial vision. Our 1.0 for iPad was launched at ASN Kidney Week in Atlanta. Internally, we described the project as building a bridge across a gorge. This 1.0 is like a piece of dental floss connecting the two sides. It is an important step but it we have big plans for future versions.
We have received a lot of feedback on the initial release and the overwhelming requests are: Android, iPhone, Android, iPhone, Android, iPhone.
We are going to do both, but neither are the next step. The 1.0 version is essentially a PDF reader with all 9 KDIGO guidelines pre-loaded. Moving the app to Android and the iPhone will entail porting all of the guidelines to a new data model. We have a big vision for the product and are reworking the infrastructure to get there. Those two updates will come but they need to wait for the new data structure, for now, the only thing I can tell you is: Patience.
The current version of KDIGO Mobile has a community option that is a ghost town. We are going to tear that down and instead adopt the renal community on Twitter. The new social section will have a number of ways to view twitter that are designed to expose new people to the vibrant nephrology discussions that occur in there.
Users will have a number of twitter channels that they can tune into:
All of these channels are stored on the servers at Visible Health so they can be controlled remotely and are eternally updatable.
Today, we are asking members of the nephrology social media sphere to look at the lists, try out the timelines, explore the hashtags. Tell us if we missed anyone or added someone undeserving.
When evaluating the timelines keep in mind the goal of these Twitter channels. We want to introduce new users to the utility of twitter for nephrology discussions. The timeline that I am most concerned about is the proximal tubule. The collecting tubule is an official channel and will likely be pretty dry. The glomerulus I think will be too much of a fire hydrant and I am thinking about dropping that channel altogether. I’m hoping that the proximal tubule can have relevant, compelling, content to really show off the utility of Twitter to naive KDIGO users.
Any and all feedback would be appreciated.
SYMPLICITY-3 was Medtronic’s play to get into the hypertension business. They have a device that allows physicians to apply burn the sympathetic nerves of the renal arteries and lower the blood pressure. In a previous randomized trial it worked and SYMPLICITY-3 was what they were going to take to the FDA to get approval.
I started the day with our local hypertension guru explaining the inclusion criteria for Symplicity-4. An hour later this hit the wire:
![]() |
| Full press release |
I was a huge fan of renal denervation and a bit of me died when the tweets started flying. Our local Symplicity PI says that the follow-up study with looser enrollment criteria, SYMPLICITY-4, has been cancelled. MedTronic supposedly is still going to carryout a trial of renal artery sympathetic nerve ablation in heart failure. If that is positive then it is possible the field will carry on, but if they abandon that, it may be lights out for the entire concept.
First CORAL, now SYMPLICITY 3. It’s been a bad couple of months for the renal arteries. They should get a better PR person.
— Joel Topf (@kidney_boy) January 9, 2014
Some thoughts on simplicity 3. The trial was on patients with severe resistant hypertension: office blood pressure over 160 on three blood pressure medications. These are hardcore hypertensives. This may not be an appropriate crucible to test the hypothesis of weather this works.
I give monthly lectures to the residents at three hospitals. I bill the lectures as a comprehensive, year-long, fluid and electrolyte course. I have never established a fixed curriculum for the lectures, here is one take:
Kidney TREKS is a program for medical students who want to learn about nephrology. Here are the components of the program from the website:
| Imagine hiking around this beautiful island after learning the secretes of glomerular filtration. |
| Mount Desert Island Biologic Lab, home to the world’s nerdiest fence. |
The highest potassium I have ever seen? That would be 15.5 mEq/L.
It’s not real. It was pseudohyperkalemia from leukocytosis. The patient had chronic lymphocytic leukemia with a white count of 300,000. If you are not familiar with this condition, check out these posts on Renal Fellow Network: Westervelt and Nate. Nice full text references here and here (pdf).
![]() |
| The pseudohyperkalemia merit badge |
The first time I saw this was when I was senior resident. I was sleeping in the call room my pager buzzed. It was the oncology floor with a potassium of 9. The patient had CML and was in a blast crisis. His leukocyte count around 100,000. I immediately suspected pseudohyperkalemia and ordered a whole blood potassium from the ABG lab. It was normal so I went back to sleep. The next morning I received an angry call from the Hemo-Onc fellow. The patient was coding and he was furious that I only ordered an ABG instead of treating the hyperkalemia.
I don’t know if the patient coded from hyperkalemia, but I wish that I had gotten out of bed and evaluated the patient. I solved the problem the nurses alerted me to, but if I assessed him, maybe I could of averted an arrest.
Regrets…
Dallas is Area Code 214. I wonder if they appreciate that 214 really represents the 3 types of RTA in anatomic order?
— Joel Topf (@kidney_boy) January 7, 2014
This morning I was trying to imagine the mad electrolyte gurus of UT Southwestern in Dallas influencing the naming of the RTAs to match their Area code. Well played Donald Seldin, well played.
Not to be outdone, Dalya Munves joined in the area code and medicine game.
@kidney_boy other Dallas area code is 972, which is imprinted on amphetamine/dextroamphetamine tabs! #ADHDpride
— The Health Scout (@HealthScoutBlog) January 7, 2014
@HealthScoutBlog that’s why on the street they are call Ewings #ImMakingThisUp pic.twitter.com/sAVc4Wixvb
— Joel Topf (@kidney_boy) January 7, 2014
Any other area code-medicine mash-ups out there?
Note. The following 5 paragraphs from Douglas Coupland’s Microserfs that I read in 1995 has stayed with me since then. Love this minutia:
“Maybe. But let me digress a bit. Here’s something interesting . . . did you know you can figure out how important your state or province was circa 1961 by adding up the code’s three digits? Zero equals 10.”
“No.”
“It’s because zeros used to take forever to go around the little rotary dial-while ones zipped along quickest. The lowest possible code, 212, went to the busiest place, New York City. Los Angeles got 213. Alaska got 907. See my point?”
Karla always comes up with the best digressions. “Yes.”
“Imagine Angie Dickinson in Los Angeles (213) telephoning Suzanne Pleshette in Las Vegas (702) sometime before the Kennedy assassination. She dials the final ‘2,’ breaks a fingernail, and cusses a shit under her breath, irritated at Suzanne for being in a location with a loser area code.”
2013 was a great year for the blog and for social media in nephrology. After a down year in 2012 for PBFluids, only 57 posts all year, I bounced back by nearly doubling that productivity with 112 posts last year. One of my most productive years. But to me the most remarkable change has been the emergence of a nephrology community in social media. My posts here at PBFluids certainly dripped with social media. Here is the year in review month by month.
@MGKatz036 Stop that NaCl its the reason he’s not doing well In order to volume resuscitate The hip new thing is Ringers Lactate
— Joel Topf (@kidney_boy) April 18, 2013
On Sunday the story broke that a single center study had found increased AKI with the combination of Vancomycin and Pipercillin-Tazobactam.
There was an interesting and in depth discussion of the issues on Twitter. I captured the major points this Storify: